Company Overview and News

 
Hindustan Wires extends rally; hits 5% upper circuit

2017-01-02 indiainfoline
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

 
Trading suspended in 31 companies from March 31; shares plunge up to 20%

2016-03-29 financialexpress
Shares of CMI Ltd, Risa International, Cupid, Frontline Business Solutions and Lykis hit lower circuit in Tuesday’s trade after the BSE on Monday decided to suspend trading in shares of these companies from Thursday. The list includes another 26 companies which will also be suspended from March 31 (See table).

 
BSE to suspend trading in 31 companies from March 31

2016-03-29 financialexpress
Continuing with its efforts to curb manipulative activities on its platform, the BSE on Monday decided to suspend trading in shares of as many as 31 companies from Thursday.

 
Surveillance measure: BSE to suspend trading in 31 cos

2016-03-29 moneycontrol
The move came less than a month after the exchange had cautioned about substantial increase in manipulation/abrupt movement in the prices of securities wherein common modus operandi was found to be through preferential allotment route.

 
Surveillance measure: BSE to suspend trading in 31 cos

2016-03-29 moneycontrol
The move came less than a month after the exchange had cautioned about substantial increase in manipulation/abrupt movement in the prices of securities wherein common modus operandi was found to be through preferential allotment route.

 
BSE to suspend trading in 31 companies effective March 31

2016-03-28 business-standard
Continuing with its efforts to curb manipulative activities on its platform, the Bombay Stock Exchange Monday decided to suspend trading in shares of as many as 31 companies from Thursday. The move came less than a month after the exchange had cautioned about substantial increase in manipulation/abrupt movement in the prices of securities wherein common modus operandi was found to be through preferential allotment route.

 
Surveillance measure: BSE to suspend trading in 31 cos

2016-03-28 timesofindia.indiatimes
New Delhi, Mar 28 () Continuing with its efforts to curb manipulative activities on its platform, the BSE today decided to suspend trading in shares of as many as 31 companies from Thursday.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...